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A B S T R A C T
Background
The space and time distribution of risk factors for allergic diseases may provide insights into
disease mechanisms. Allergy is believed to vary by month of birth, but multinational studies
taking into account latitude have not been conducted.
Methods and Findings
A questionnaire was distributed in 54 centres to a representative sample of 20- to 44-y-old
men and women mainly in Europe but also including regions in North Africa, India, North
America, Australia, and New Zealand. Data from 200,682 participants were analyzed. The
median prevalence of allergic rhinitis was 22%, with a substantial variation across centres.
Overall, allergic rhinitis decreased with geographical latitude, but there were many exceptions.
No increase in prevalence during certain winters could be observed. Also, no altered risk by
birth month was found, except borderline reduced risks in September and October. Effect
estimates obtained by a multivariate analysis of total and specific IgE values in 18,085
individuals also excluded major birth month effects and confirmed the independent effect of
language grouping.
Conclusion
Neither time point of first exposure to certain allergens nor early infections during winter
months seems to be a major factor for adult allergy. Although there might be effects of climate
or environmental UV exposure by latitude, influences within language groups seem to be more
important, reflecting so far unknown genetic or cultural risk factors.
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Introduction
Allergy prevalence has been on the rise in many countries,
while causal risk factors are still unknown [1]. The spatial and
temporal distribution of risk factors may offer an insight into
the mechanism of disease.
Birth month has been claimed to be associated with allergy.
More than half of the studies summarized in our ﬁrst analysis
of birth month and allergy in 1992 [2] showed a positive
association of month of birth with various allergy outcomes
[3–19]. A few studies missed at that time, as well as most
consecutive studies [20–36] do not show a consistent relation-
ship.
Birth month has been used as a proxy for early allergen
exposure but may also be associated with upper respiratory
infections during certain winter months. At least in Europe,
exposure to outdoor allergens is expected to occur in
annually ﬁxed ﬂowering intervals, while episodes of respira-
tory infections are encountered in autumn and winter
months with variation between years. Any autumn or winter
season of birth effect could give further support the hygiene
hypothesis [37] that postulates a reduction of natural
infection, which is responsible for an over-reactive immune
system, ﬁnally leading to allergy.
Geographical latitude so far has been associated with
different diseases such as Crohn disease [38] or type I diabetes
[39] but only sporadically with allergy [40]. Latitude is usually
described as a proxy for UV solar exposure, as radiation
reaching the earth’s surface varies inversely with latitude. It
may also reﬂect climatic differences responsible for different
pollen seasons, as well as different building construction. In
addition, many other factors are associated with geographical
latitude in Europe, such as genetic inﬂuences or cultural
differences in raising children.
The aim of this analysis was, therefore, to further delineate
latitude and birth date effects on the prevalence of allergy
deﬁned by markers such as allergic rhinitis (AR), sensitization
to grass or dust, and total IgE levels.
Methods
Sample
The methods for the European Community Respiratory
Health Study (ECRHS) I were published earlier [41], with
protocols and questionnaires available from the study Web
site (http://www.ecrhs.org). Brieﬂy, ECRHS I participating
centres were each selected from an area deﬁned by pre-
existing administrative boundaries, with a population of at
least 150,000 people. An up-to-date sampling frame was used
to randomly select at least 1,500 men and 1,500 women aged
20 to 44 y. All individuals were sent a questionnaire enquiring
about respiratory symptoms and attacks of asthma in the last
12 mo, current use of asthma medication, and nasal allergies
including hayfever (ECRHS I screening). This sample consists
of 54 centres with 200,682 participants. For this analysis, the
study centre Aarhus and part of Erfurt probands were
excluded because of unreliable birth dates, in addition to
all individuals with wrong or missing birth dates and all born
on the 29th of February. Also, only birth years from 1945
until 1973 were included, as all other birth years did not have
enough observations to be reliable. The ﬁnal dataset included
186,723 individuals (Table 1). The main outcome variable in
this dataset was the response to the question ‘‘Do you have
any nasal allergies including ‘hayfever’?’’ Given 16,000
exposed persons in a single month compared to 16,000 born
in a reference month with an assumed disease prevalence of
22% and a given a of 0.05, an increase of 1% in the exposed
group would have been found with a power of 57% in a two-
tailed test, while an increase of 2% would have been found
with a power of 99%.
A random sample of these individuals was selected to take
part in the full study (ECRHS I main, in joint papers
denominated stage II), during which they were invited to
visit a local testing centre, answer a more detailed
questionnaire, provide a blood sample for measurement of
speciﬁc IgE and total IgE, perform baseline spirometry, and
undergo bronchial challenge with methacholine. Informed
consent was obtained from 60% of invited participants [42].
All study protocols were approved by the local ethics
committees. Blood samples were all handled in a similar
manner and analysed in a central laboratory (Pharmacia,
Uppsala, Sweden). Brieﬂy, blood samples were centrifuged
and serum stored at 20 8C until total IgE and speciﬁc IgE
analysis (Radio AllergoSorbent Test [RAST]), of which only
mixed grass and house dust mite were used in this study.
RAST class 1 or greater was considered as a positive antibody
test. All total IgE values were log-transformed and tested on
a continuous scale. Numbers under analysis are given in
Table 1.
Exposure
The following birth-related variables were deﬁned from the
questionnaire: sinus(day of year [1,...,365]); day of month
(1,. . .,31); day of week (1¼ Sunday,.., 7¼ Saturday); month of
year (1 ¼ Jan,. . .,12 ¼ Dec); season (1 ¼ Dec/Jan/Feb, . . ., 4 ¼
Sep/Oct/Nov); annual season (1/1945, . . ., 4/1973) and year of
birth (1945,. . .,1973). Reported in this study are only month,
year, and quarter of birth year, as none of the other variables
showed any additional information.
Geographical latitude was obtained from the route plan-
ning software Mapsonic (http://www.viamichelin.com), where
GPS degrees were obtained for a random inner city point and
were included as a continuous variable as well as dichotom-
ized into quartile groups. Non-European locations were taken
from The World Gazetteer (http://www.world-gazetteer.com)
or Encarta (http://encarta.msn.com). For Figures 1 and 2, the
original latitude values are used, while for all regression
models only the absolute latitude values are taken. If primary
language was not self evident, the CIA’s World Factbook
(http://www.cia.gov/cia/publications/factbook/ﬁelds/2098.html)
was used as a reference. The city of Montreal was classiﬁed as
English, although English/French bilingual questionnaires
were used. Additional data included in this study are
obtained from http://rimmer.ngdc.noaa.gov/mgg/coast/
getcoast.html, http://www.polleninfo.org, and http://www.
dssresearch.com/toolkit/spcalc/power_p2.asp.
Analysis
In an initial step, Trellis barcharts and boxplots [43] were
created for all date and latitude variables in the ECRHS I
screening sample and contingency tables analysed using
global v2 tests. In a second step this analysis was repeated
in ECRHS I main study for AR, total IgE, RAST grass, and
RAST house dust. Heterogeneity across centres was assessed
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using meta-analysis with latitude included as a random effect
[44]. Next, generalised linear equations were ﬁtted with a
binomial outcome for categorical and Gaussian outcome for
IgE values. Analyses were conducted for single risk factors
alone (Table 2), followed by the joint inclusion of all factors
(Table 3). Open-source R software 2.0.1 was used for all
analyses (http://www.r-project.org).
Results
A history of AR was reported in the screening question-
naire with a range from 2.4% in Nancy to 41.1% in
Melbourne (Table 1). Participants reported on median a
prevalence of 22.2%, while the prevalence in ECRHS I main
was slightly higher, reaching 27.4% (Table 1).
Table 1. Lifetime Prevalence of AR and Prevalence of Positive RAST Values by Centre in ECRHS I Screening
Latitude ERCHS I Screening AR ECRHS I Main AR ECRHS I Main RAST Grass ECRHS I Main RAST Dust
Degree n N % n N % n N % n N %
Albacete 38 410 3,389 12.1 137 626 21.9 69 558 12.4 43 558 7.7
Algiers 36 301 3,026 9.9 — — — — — — — — —
Antwerp City 51 742 2,941 25.2 202 644 31.4 47 284 16.5 79 284 27.8
Antwerp South 51 637 3,046 20.9 159 627 25.4 68 380 17.9 95 380 25.0
Athens 37 613 3,323 18.4 — — — — — — — — —
Auckland 36 1,041 2,940 35.4 — — — — — — — — —
Barcelona 41 358 2,705 13.2 112 512 21.9 37 244 15.2 74 244 30.3
Basel 47 1,204 4,992 24.1 297 966 30.7 260 701 37.1 144 701 20.5
Bergen 60 660 3,362 19.6 141 809 17.4 114 749 15.2 107 749 14.3
Bergen-op-Zoom 51 695 3,351 20.7 — — — — — — — — —
Bombay 18 152 1,698 9.0 — — — — — — — — —
Cambridge 52 741 2,578 28.7 — — — — — — — — —
Cardiff 51 550 2,325 23.7 156 504 31.0 84 423 19.9 131 423 31.0
Christchurch 43 1,094 3,023 36.2 — — — — — — — — —
Coimbra 40 290 1,758 16.5 — — — — — — — — —
Dublin 53 484 2,390 20.3 — — — — — — — — —
Erfurt 50 427 3,207 13.3 85 722 11.8 143 713 20.1 111 713 15.6
Galdakao 43 376 3,000 12.5 105 589 17.8 65 452 14.4 114 452 25.2
Geleen 50 790 3,326 23.8 104 408 25.5 92 388 23.7 115 388 29.6
Goteborg 57 633 2,862 22.1 235 857 27.4 152 718 21.2 102 718 14.2
Grenoble 45 811 2,926 27.7 190 521 36.5 89 479 18.6 90 479 18.8
Groningen 53 720 3,076 23.4 — — — — — — — — —
Halifax Nova Scotia 44 885 2,854 31.0 — — — — — — — — —
Hamburg 53 744 3,224 23.1 316 1,231 25.7 199 761 26.1 146 761 19.2
Hamilton 43 1,106 3,327 33.2 — — — — — — — — —
Hawkes Bay 39 1,145 2,976 38.5 — — — — — — — — —
Huelva 37 388 2,200 17.6 122 389 31.4 77 320 24.1 63 320 19.7
Ipswich 52 903 3,371 26.8 187 551 33.9 114 438 26.0 116 438 26.5
Kilkenny 52 325 1,631 19.9 — — — — — — — — —
Melbourne 37 1,306 3,178 41.1 428 870 49.2 236 701 33.7 274 701 39.1
Montpellier 43 1,281 3,721 34.4 193 455 42.4 62 364 17.0 77 364 21.2
Montreal 45 888 2,878 30.9 — — — — — — — — —
Nancy 48 30 1,260 2.4 — — — — — — — — —
Norwich 52 882 3,122 28.3 201 576 34.9 138 451 30.6 151 451 33.5
Oviedo 43 389 2,918 13.3 104 524 19.8 41 371 11.1 88 371 23.7
Paris 48 918 2,989 30.7 229 625 36.6 65 531 12.2 118 531 22.2
Pavia 45 102 814 12.5 48 309 15.5 33 250 13.2 30 250 12.0
Pessac 44 889 2,920 30.4 215 542 39.7 102 512 19.9 178 512 34.8
Portland 43 1,155 2,951 39.1 347 838 41.4 139 403 34.5 87 403 21.6
Porto 41 389 2,069 18.8 — — — — — — — — —
Prince Edward Isl. 46 814 3,218 25.3 — — — — — — — — —
Reykjavik 64 508 2,855 17.8 147 635 23.1 86 592 14.5 57 592 9.6
Sevilla 37 335 2,144 15.6 — — — — — — — — —
Tartu 58 413 2,302 17.9 124 523 23.7 43 417 10.3 46 420 11.0
Torino 45 402 2,504 16.1 84 355 23.7 54 252 21.4 27 252 10.7
Umea 63 694 3,289 21.1 225 708 31.8 121 548 22.1 65 548 11.9
Uppsala 59 693 3,119 22.2 270 811 33.3 166 695 23.9 69 695 9.9
Vancouver 49 1,035 2,865 36.1 — — — — — — — — —
Verona 45 455 2,701 16.8 76 358 21.2 65 351 18.5 46 351 13.1
Wellington 41 1,112 3,032 36.7 — — — — — — — — —
Wien 48 346 2,129 16.3 — — — — — — — — —
Winnipeg 49 826 2,895 28.5 — — — — — — — — —
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There was a substantial variation between centres in the
frequency of sensitization against mixed grass allergen,
ranging from 10.3% in Tartu up to 37.1% in Basel. Dust
mite sensitization was high in Melbourne, Norwich, and
Pessac, and low in Albacete, Reykjavik, and Uppsala.
All centres (Figure 1) were then ordered by geographical
latitude (Figure 2). Latitudes covered in Europe includeþ37 8
(Huelva in Spain) up toþ64 8 (Reykjavik in Iceland). Overall,
AR decreased with geographical latitude, but there were
many exceptions (Figures S1–S12).
The analysis of birth dates in ECRHS I screening did not
show any signiﬁcant effect, neither for day of year, day of
month, nor day of week. Crude risks by birth month in
ECRHS I main were also not increased, while in the adjusted
analysis only September (OR 0.75; 0.56–1.01) and October
(OR 0.75; 0.56–1.00) reached borderline signiﬁcant reduced
risks compared to birth month January.
When tested for heterogeneity according to centre, only
birth month May showed signiﬁcant centre differences (p ¼
0.021). There may be even more altered risks at the single
centre level (like Huelva in January, Montpellier in February,
etc.; see Figures S9 for ECRHS I screening and Figure S20 for
ECRHS I main), but the overall number of associations does
not seem to exceed the number expected by chance.
AR prevalence was high even in the earliest birth cohorts
(Figures S1–S11 for ECRHS I screening and Figures S12–S22
for ECRHS I main). Analysing birth date in increasing 3-mo
intervals did not reveal any major spike that could be
attributed to a seasonal inﬂuence of winter months or the
known inﬂuenza A pandemic years in 1957 and 1968 [45].
Finally, effects were analysed by generalized linear regres-
sion models in ECRHS I main (Table 2) that also controlled
for confounding effects (Table 3). Factors with signiﬁcant
inﬂuence on AR in the adjusted model are a history of AR in
the parents, current smoking, latitude, and language. There
was also a signiﬁcant effect by year of birth, but none by
Figure 1. World Map and European Map of Study Centres
DOI: 10.1371/journal.pmed.0020294.g001
Figure 2. Prevalence of AR in ECRHS I Screening by Centre
Centres are sorted by increasing geographical latitudes from left to right.
DOI: 10.1371/journal.pmed.0020294.g002
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month of birth except for borderline reduced risks by being
born in September or October. Latitude was negatively
associated with AR (overall OR 0.85 per ten-degree increase, p
, 0.0001 if included as a continuous variable).
Language appeared to be an independent factor from
latitude and was in some instances an even stronger predictor
for AR (Table 3). Language group affects not only AR and
speciﬁc sensitization to all tested allergens, but also total IgE
values. The most prominent effect compared to English
language was seen for the Spanish language.
While risks for total and speciﬁc IgE were usually
concordant, risks dissociated in the Italian group (OR for
IgE grass 0.55, but 1.69 for total IgE), raising the question of
further modifying factors of total IgE in Italy. AR and grass
speciﬁc IgE were also discordant in the French centres,
raising questions about labelling of AR in France (or the
speciﬁcity of the tested allergens for AR there).
Discussion
We describe a high prevalence of AR with a substantial
variation across centres but do not ﬁnd any major risk by
being born in a particular month or during a particular
season.
The main advantage of this study is the use of standardized
interviews and identical laboratory methods, which leads to
the conclusion that the geographical differences are real and
not an artefact of non-comparable methods [46]. There is also
less concern about non-response, since non-responder differ-
ences in the main outcome variables were relatively small
[46]. Another beneﬁt is the power of the study due to the high
number of participants.
Previous studies of birth months showed mixed results. Due
to the different deﬁnitions and outcomes used, studies can
roughly be grouped into those with a positive [5–7,9,10,12–
19,21,24,26,29,30,32–36], negative [3,4,8,27,47], or even un-
Table 2. Crude Risk for AR, Total IgE, and Sensitization against Grass or House Dust Mite in ECRHS I Main Study
Variable Value AR RAST Grass RAST Dust Log (total IgE)
OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p
Month of birth Jan 1.00 1.00 1.00 1.00
Feb 0.96 0.81 1.15 0.6688 1.09 0.88 1.36 0.4292 1.07 0.85 1.33 0.5695 0.94 0.82 1.08 0.3512
Mar 0.99 0.84 1.17 0.8960 1.00 0.81 1.24 0.9984 0.91 0.73 1.13 0.4108 0.89 0.78 1.02 0.0824
Apr 0.94 0.80 1.12 0.5178 1.01 0.81 1.26 0.9170 0.91 0.73 1.13 0.3954 0.88 0.77 1.01 0.0756
May 0.86 0.72 1.02 0.0794 0.99 0.80 1.24 0.9510 1.08 0.87 1.34 0.4817 0.88 0.77 1.01 0.0672
Jun 0.90 0.76 1.07 0.2400 1.00 0.80 1.24 0.9788 0.90 0.72 1.12 0.3391 0.82 0.72 0.94 0.0046
Jul 1.02 0.86 1.21 0.7991 1.15 0.93 1.43 0.1918 1.11 0.90 1.38 0.3291 1.00 0.87 1.15 0.9832
Aug 0.88 0.74 1.05 0.1526 1.02 0.82 1.27 0.8633 0.90 0.72 1.13 0.3724 0.86 0.75 0.99 0.0343
Sep 0.85 0.71 1.01 0.0720 0.94 0.75 1.17 0.5626 0.98 0.79 1.23 0.8859 0.99 0.86 1.13 0.8536
Oct 0.92 0.77 1.09 0.3310 1.08 0.86 1.34 0.5162 0.93 0.74 1.16 0.5304 0.99 0.86 1.14 0.9088
Nov 0.89 0.75 1.07 0.2178 0.98 0.78 1.23 0.8476 0.99 0.79 1.24 0.9136 0.93 0.81 1.07 0.3348
Dec 0.97 0.82 1.16 0.7644 1.09 0.87 1.36 0.4469 1.01 0.80 1.26 0.9592 0.87 0.76 1.01 0.0601
Year of birth (1946; 1951] 1.00 1.00 1.00 1.00
(1951; 1956] 1.10 0.98 1.23 0.1135 1.24 1.06 1.44 0.0060 1.05 0.91 1.23 0.4936 1.02 0.94 1.12 0.6120
(1956; 1961] 1.10 0.98 1.23 0.1039 1.32 1.14 1.53 0.0003 1.30 1.12 1.51 0.0004 1.13 1.03 1.23 0.0090
(1961; 1965] 1.13 1.00 1.27 0.0435 1.60 1.37 1.87 ,0.0001 1.48 1.27 1.72 ,0.0001 1.16 1.05 1.27 0.0023
(1965; 1972] 1.06 0.94 1.19 0.3268 1.82 1.58 2.11 ,0.0001 1.43 1.24 1.66 ,0.0001 1.22 1.12 1.34 ,0.0001
Absolute latitude (8) (36.2; 44.1] 1.00 1.00 1.00 1.00
(44.1; 47.5] 1.13 1.01 1.27 0.0343 1.39 1.20 1.62 ,0.0001 1.13 0.97 1.31 0.1129 1.24 1.13 1.35 ,0.0001
(47.5; 51.2] 0.94 0.83 1.06 0.2895 1.08 0.92 1.26 0.3665 1.26 1.08 1.46 0.0026 1.12 1.02 1.23 0.0181
(51.2; 57.7] 1.03 0.92 1.16 0.5689 1.41 1.21 1.64 ,0.0001 1.14 0.98 1.32 0.0867 0.74 0.68 0.81 ,0.0001
(57.7; 64.1] 0.77 0.69 0.87 ,0.0001 0.89 0.76 1.05 0.1671 0.53 0.45 0.62 ,0.0001 0.65 0.59 0.71 ,0.0001
Gender Female 1.00 1.00 1.00 1.00
Male 0.92 0.86 0.99 0.0253 1.45 1.33 1.59 ,0.0001 1.64 1.49 1.80 ,0.0001 1.39 1.31 1.47 ,0.0001
History of AR No 1.00 1.00 1.00 1.00
Yes 2.47 2.28 2.68 ,0.0001 1.73 1.56 1.91 ,0.0001 1.28 1.15 1.42 ,0.0001 1.12 1.05 1.20 0.0005
Current No 1.00 1.00 1.00 1.00
Smoking Yes 0.69 0.62 0.76 ,0.0001 1.01 0.89 1.15 0.8819 1.20 1.06 1.36 0.0049 1.39 1.29 1.50 ,0.0001
Language English 1.00 1.00 1.00 1.00
French 1.14 1.02 1.29 0.0272 0.58 0.49 0.68 ,0.0001 0.92 0.79 1.06 0.2478 1.74 1.57 1.92 ,0.0001
German 0.53 0.47 0.60 ,0.0001 1.02 0.89 1.18 0.7421 0.61 0.52 0.71 ,0.0001 1.08 0.98 1.19 0.1274
Italian 0.42 0.35 0.51 ,0.0001 0.62 0.50 0.77 ,0.0001 0.40 0.32 0.51 ,0.0001 1.54 1.35 1.76 ,0.0001
Nordic 0.50 0.45 0.57 ,0.0001 0.58 0.50 0.67 ,0.0001 0.35 0.30 0.41 ,0.0001 0.74 0.68 0.81 ,0.0001
Other 0.58 0.51 0.66 ,0.0001 0.58 0.48 0.69 ,0.0001 0.80 0.68 0.95 0.0093 1.13 1.01 1.26 0.0281
Spanish 0.36 0.31 0.41 ,0.0001 0.42 0.35 0.51 ,0.0001 0.59 0.49 0.70 ,0.0001 1.15 1.03 1.28 0.0113
Profession Self-employed 1.00 1.00 1.00 1.00
Chief executive 1.27 1.07 1.50 0.0068 0.98 0.78 1.22 0.8421 1.17 0.94 1.45 0.1604 1.06 0.93 1.22 0.3700
Foreman. executive 1.12 0.96 1.31 0.1479 0.95 0.78 1.15 0.5869 0.99 0.82 1.21 0.9424 1.00 0.89 1.13 0.9598
Worker. employee 0.92 0.82 1.04 0.1882 0.96 0.83 1.12 0.6269 0.96 0.83 1.13 0.6493 0.98 0.90 1.08 0.7514
Unclassified 1.07 0.91 1.24 0.4181 1.38 1.14 1.67 0.0011 1.31 1.08 1.59 0.0068 1.20 1.06 1.36 0.0037
DOI: 10.1371/journal.pmed.0020294.t002
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clear outcome [20,22,23,28,31]. Without applying formal
criteria of a meta-analysis, these studies are difﬁcult to sort.
Some are case-only studies, others depend on cross-sectional
data, and only a few are cohort studies. A detailed knowledge
of local circumstances would be necessary to integrate all
results into a larger framework. Also, this study agrees that
there might be relevant birth month effects in single centres,
but it questions any global effect.
Taking into account publication bias, it may be under-
standable that in published studies the positive results
outnumber negative ones. Most of the previous studies
showed an association with allergic sensitization (and not so
often with AR), which may indicate subclinical effects that
may gain importance only when occurring in combination
with additional risk factors. One of the main advantages of
our study—the standardized allergen test protocol—might
be a disadvantage where the effects of local allergens might
have been missed. An exposure matrix constructed by
ﬂowering season in all participating European centres did
not result in a different risk estimate (unpublished data; see
Materials and Methods).
A further difference in comparison with many previous
studies is the higher age of our study participants. It may be
possible that more marked symptoms exist in children, that
are being lost in adulthood. We are sharing, however, a
methodological problem with most previous studies, as we are
assuming that current residence is identical with residence of
birth, which might not always be true. For those participating
in our main study, migration was limited [48] and is probably
not leading to a distortion of study results.
Another methodological restriction may be the use of
self-reported ‘‘hayfever.’’ This term might be used in a
different way across Europe, and there might be secular
changes in the labelling. The more or less negative ﬁnding
for any particular birth month (together with the results for
speciﬁc IgE against grass) in our study, however, is rather
Table 3. Adjusted Risk for AR, Total IgE, and Sensitization against Grass or House Dust Mite in ECRHS I Main Study
Variable Value AR RAST Grass RAST Dust Log (Total IgE)
OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p
Month of birth Jan 1.00 1.00 1.00 1.00
Feb 1.05 0.79 1.39 0.7355 0.96 0.68 1.35 0.8187 0.98 0.71 1.36 0.9088 1.01 0.83 1.23 0.8984
Mar 0.95 0.72 1.24 0.6954 0.89 0.63 1.25 0.5017 0.76 0.55 1.06 0.1073 0.88 0.73 1.06 0.1820
Apr 0.88 0.66 1.16 0.3518 0.98 0.70 1.36 0.8930 0.79 0.57 1.10 0.1666 0.86 0.71 1.04 0.1186
May 0.86 0.65 1.14 0.3072 0.75 0.53 1.08 0.1189 1.00 0.72 1.37 0.9864 0.87 0.71 1.05 0.1450
Jun 0.91 0.69 1.20 0.4982 0.92 0.66 1.28 0.6133 0.88 0.64 1.22 0.4445 0.86 0.71 1.04 0.1094
Jul 1.09 0.83 1.43 0.5320 1.11 0.79 1.55 0.5439 0.88 0.63 1.22 0.4357 0.94 0.78 1.14 0.5500
Aug 0.89 0.67 1.18 0.4166 0.80 0.56 1.15 0.2316 0.83 0.59 1.16 0.2665 0.80 0.66 0.97 0.0259
Sep 0.75 0.56 1.01 0.0616 0.89 0.62 1.26 0.5002 0.88 0.63 1.23 0.4406 0.96 0.79 1.17 0.6884
Oct 0.75 0.56 1.00 0.0528 0.86 0.61 1.22 0.3964 0.79 0.57 1.11 0.1750 0.89 0.74 1.09 0.2550
Nov 0.84 0.62 1.13 0.2505 0.91 0.63 1.30 0.5960 0.82 0.58 1.16 0.2593 0.92 0.75 1.12 0.4121
Dec 1.08 0.82 1.44 0.5692 1.09 0.77 1.53 0.6356 0.96 0.69 1.34 0.8248 0.86 0.70 1.05 0.1326
Year of birth (1946; 1951] 1.00 1.00 1.00 1.00
(1951; 1956] 1.25 1.05 1.49 0.0144 1.23 0.98 1.53 0.0715 1.08 0.88 1.34 0.4579 1.03 0.91 1.15 0.6570
(1956; 1961] 1.25 1.04 1.50 0.0174 1.16 0.92 1.46 0.2137 1.34 1.08 1.66 0.0085 1.04 0.92 1.17 0.5312
(1961; 1965] 1.30 1.07 1.59 0.0082 1.53 1.20 1.95 0.0006 1.50 1.19 1.89 0.0005 1.04 0.91 1.19 0.5382
(1965; 1972] 1.29 1.04 1.59 0.0178 1.81 1.42 2.32 ,0.0001 1.44 1.13 1.83 0.0030 1.05 0.91 1.20 0.5251
Absolute latitude (8) (36.2; 44.1] 1.00 1.00 1.00 1.00
(44.1; 47.5] 0.72 0.54 0.95 0.0225 0.89 0.61 1.29 0.5352 1.48 1.02 2.16 0.0404 0.89 0.71 1.12 0.3103
(47.5; 51.2] 0.55 0.41 0.74 0.0001 0.54 0.37 0.80 0.0020 1.50 1.02 2.19 0.0391 1.04 0.82 1.31 0.7559
(51.2; 57.7] 0.77 0.59 1.02 0.0645 0.59 0.41 0.84 0.0036 1.55 1.07 2.25 0.0195 0.77 0.61 0.96 0.0190
(57.7; 64.1] 0.58 0.40 0.83 0.0033 0.36 0.22 0.57 ,0.0001 0.95 0.59 1.52 0.8243 0.69 0.52 0.90 0.0073
Gender Female 1.00 1.00 1.00 1.00
Male 1.03 0.91 1.16 0.6568 1.51 1.30 1.76 ,0.0001 1.77 1.53 2.04 ,0.0001 1.33 1.23 1.45 ,0.0001
History of AR No 1.00 1.00 1.00 1.00
Yes 2.16 1.91 2.44 ,0.0001 1.65 1.41 1.92 ,0.0001 1.18 1.01 1.38 0.0355 1.18 1.08 1.29 0.0003
Current No 1.00 1.00 1.00 1.00
Smoking Yes 0.72 0.64 0.82 ,0.0001 1.00 0.85 1.16 0.9549 1.21 1.04 1.41 0.0139 1.34 1.23 1.46 ,0.0001
Language English 1.00 1.00 1.00 1.00
French 1.29 0.98 1.69 0.0683 0.60 0.42 0.85 0.0045 0.92 0.65 1.29 0.6186 1.62 1.32 2.00 ,0.0001
German 0.69 0.54 0.88 0.0024 1.18 0.87 1.60 0.2811 0.51 0.38 0.69 ,0.0001 1.02 0.85 1.23 0.7976
Italian 0.67 0.46 0.97 0.0352 0.55 0.35 0.86 0.0084 0.39 0.25 0.62 0.0001 1.69 1.30 2.20 0.0001
Nordic 0.65 0.48 0.89 0.0062 1.00 0.69 1.44 0.9808 0.49 0.34 0.70 0.0001 0.93 0.76 1.15 0.5253
Other 0.96 0.70 1.31 0.8062 0.94 0.63 1.39 0.7413 0.88 0.61 1.27 0.5056 1.02 0.82 1.28 0.8536
Spanish 0.38 0.28 0.51 ,0.0001 0.33 0.22 0.50 ,0.0001 0.72 0.48 1.08 0.1109 0.99 0.78 1.26 0.9306
Profession Self-employed 1.00 1.00 1.00 1.00
Chief executive 0.90 0.67 1.20 0.4689 0.99 0.68 1.44 0.9476 1.01 0.72 1.43 0.9364 0.94 0.77 1.15 0.5499
Foreman. executive 1.05 0.82 1.35 0.7103 1.10 0.80 1.50 0.5637 1.05 0.78 1.42 0.7447 0.96 0.81 1.13 0.6028
Worker. employee 0.90 0.74 1.10 0.3014 1.10 0.86 1.41 0.4388 1.12 0.88 1.41 0.3518 1.07 0.94 1.22 0.2952
Unclassified 1.07 0.81 1.41 0.6403 1.20 0.86 1.68 0.2824 1.42 1.03 1.97 0.0332 1.27 1.05 1.54 0.0151
DOI: 10.1371/journal.pmed.0020294.t003
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consistent across centres. It is possible that reporting of AR
during ‘‘symptom’’ months might be increased, but there is
no indication that any differential reporting is also
associated with birth date. It is therefore unlikely that
speciﬁc allergen exposure outdoors directly after birth has a
major impact on the development of AR.
So far, no data conﬁrm that allergen exposure has been
increased in parallel with AR during the recent decades. This
would be a rather likely explanation, as global climatic
changes with warming may result in higher grass pollen
exposure [49], and construction of better isolated houses may
support dust mite growth. A study on peak allergen exposure,
however, showed only an insigniﬁcant increased sensitization
[50], and even allergen avoidance trials are far from being
conclusive [51].
Any effect of winter month epidemics, in particular of
the inﬂuenza A episodes in 1957 and 1968 [45], could not be
shown. An increasing trend of asthma incidence by birth
year has already been described in this study [52] and is
now also found for AR. It may be emphasized that the
prevalence in the cohorts born directly after World War II
is already high and stable over all birth years. Unfortu-
nately, time and cohort effects cannot be discriminated, but
an effect by infection epidemics directly before or after
birth is unlikely.
Data pertaining to the geographical distribution of
allergic diseases are rare. The International Study of
Asthma and Allergies in Childhood (ISAAC) compared the
worldwide distribution of AR in children, which varied
across centres from 0.8% to 14.9% in the 6- to 7-y-olds and
from 1.4% to 39.7% in the 13- to 14-y-olds [53]. Although
the prevalence in 13- to 14-y-old children was slightly
lower, a direct comparison of 13 centres included in both
ECRHS and ISAAC showed good agreement. A worldwide
meta-analysis of ISAAC centres showed a negative associ-
ation of latitude and symptoms of AR with a 0.05%
decrease per degree (0.11; 0.00) in 6- to 7-y-olds and with
0.09% (0.18; 0.01) in 13- to 14-y-olds; effects were
attributed to climatic differences such as indoor humidity
or altitude [40]. A study in Australia also reported a
negative association of latitude and asthma [39], while
effects in this study are interpreted by UV solar radiation.
This view may be also supported by a recent study of
vitamin D supplementation and allergy [54].
AR decreased with geographical latitude, but it is unclear
why the Spanish, Portuguese, and Greek centres make such an
exception from this rule. Surprisingly, in another study the
lowest serum vitamin D metabolite concentrations were seen
in southern European countries, which could be explained by
attitudes toward sunlight exposure [55].
The lowest prevalence of AR in the ISAAC was found in
Eastern Europe and South and Central Asia, and—as in the
ECRHS—a high prevalence was reported for English-speak-
ing centres. It is intriguing that inclusion of preferential
language into the multivariate model did not resolve the
latitude effect, and even increased it.
Language may be a marker for genetic traits [56], and there
is indeed a genetic heterogeneity in this study by language
where a history of AR in the family does not countervail for
the latitude effect. A risk factor operating within language
borders therefore seems to be even more relevant than
geographical latitude alone.
Supporting Information
Figure S1. ECRHS I Screening AR Prevalence by Birth Quarter and
Centre
Found at DOI: 10.1371/journal.pmed.0020294.sg001 (298 KB PDF)
Figure S2. ECRHS I Screening AR Prevalence by Birth Quarter and
Latitude/Longitude
Found at DOI: 10.1371/journal.pmed.0020294.sg002 (105 KB PDF)
Figure S3. ECRHS I Screening AR Prevalence by Birth Quarter and
Language
Found at DOI: 10.1371/journal.pmed.0020294.sg003 (105 KB PDF)
Figure S4. ECRHS I Screening AR Prevalence by Birth Quarter and
Sex
Found at DOI: 10.1371/journal.pmed.0020294.sg004 (32 KB PDF)
Figure S5. ECRHS I Screening AR Prevalence by Month of Birth and
Centre
Found at DOI: 10.1371/journal.pmed.0020294.sg005 (87 KB PDF)
Figure S6. ECRHS I Screening AR Prevalence by Month of Birth and
Latitude/Longitude
Found at DOI: 10.1371/journal.pmed.0020294.sg006 (59 KB PDF)
Figure S7. ECRHS I Screening AR Prevalence by Month of Birth and
Language
Found at DOI: 10.1371/journal.pmed.0020294.sg007 (54 KB PDF)
Figure S8. ECRHS I Screening AR Prevalence by Month of Birth and
Sex
Found at DOI: 10.1371/journal.pmed.0020294.sg008 (48 KB PDF)
Figure S9. ECRHS I Screening AR Prevalence by Month and Year of
Birth
Found at DOI: 10.1371/journal.pmed.0020294.sg009 (66 KB PDF)
Figure S10. ECRHS I Screening AR Prevalence by Quarter and Month
of Birth
Found at DOI: 10.1371/journal.pmed.0020294.sg010 (66 KB PDF)
Figure S11. ECRHS I Screening AR Prevalence by Quarter and Month
of Birth
Found at DOI: 10.1371/journal.pmed.0020294.sg011 (51 KB PDF)
Figure S12. ECRHS I Main Median Log Total IgE by Birth Quarter
and Centre
Found at DOI: 10.1371/journal.pmed.0020294.sg012 (180 KB PDF)
Figure S13. ECRHS I Main Median Log Total IgE by Birth Quarter
and Latitude/Longitude
Found at DOI: 10.1371/journal.pmed.0020294.sg013 (120 KB PDF)
Figure S14. ECRHS I Main Median Log Total IgE by Birth Quarter
and Language
Found at DOI: 10.1371/journal.pmed.0020294.sg014 (85 KB PDF)
Figure S15. ECRHS I Main Median Log Total IgE by Birth Quarter
and Sex
Found at DOI: 10.1371/journal.pmed.0020294.sg015 (58 KB PDF)
Figure S16. ECRHS I Main Median Log Total IgE by Month of Birth
and Centre
Found at DOI: 10.1371/journal.pmed.0020294.sg016 (70 KB PDF)
Figure S17. ECRHS I Main Median Log Total IgE by Month of Birth
and Latitude/Longitude
Found at DOI: 10.1371/journal.pmed.0020294.sg017 (61 KB PDF)
Figure S18. ECRHS I Main Median Log Total IgE by Month of Birth
and Language
Found at DOI: 10.1371/journal.pmed.0020294.sg018 (53 KB PDF)
Figure S19. ECRHS I Main Median Log Total IgE by Month of Birth
and Sex
Found at DOI: 10.1371/journal.pmed.0020294.sg019 (47 KB PDF)
PLoS Medicine | www.plosmedicine.org October 2005 | Volume 2 | Issue 10 | e2940983
Latitude, Birth Date, and Allergy
Figure S20. ECRHS I Main Median Log Total IgE by Month and Year
of Birth
Found at DOI: 10.1371/journal.pmed.0020294.sg020 (67 KB PDF)
Figure S21. ECRHS I Main Median Log Total IgE by Month and
Quarter of Birth
Found at DOI: 10.1371/journal.pmed.0020294.sg021 (66 KB PDF)
Figure S22. ECRHS I Main Median Log Total IgE by Absolute
Latitude and Language
Found at DOI: 10.1371/journal.pmed.0020294.sg022 (58 KB PDF)
Acknowledgments
We wish to thank Michelle Emﬁnger for proof-reading of the
manuscript and Deepayan Sarkar for help with the lattice R package.
The ECRHS study is a joint project by many participants and funded
by many sources.
Project Leader: Peter Burney; Statistician: Sue Chinn; Principal
Investigator: Deborah Jarvis; Project Coordinator: Jill Knox; Principal
Investigator: Christina Luczynska; Assistant Statistician: J Potts; Data
Manager: S Arinze.
Steering Committee: Josep M Anto´, Institut Municipal d’Inves-
tigacio´ Me`dica (IMIM-IMAS), Universitat Pompeu Fabra (UPF); Peter
Burney, King’s College London; Isa Cerveri, University of Pavia;
Susan Chinn, King’s College London; Roberto de Marco, University of
Verona; Thorarinn Gislason, Iceland University Hospital; Joachim
Heinrich, GSF—Institute of Epidemiology; Christer Janson, Uppsala
University; Deborah Jarvis, King’s College London; Jill Knox, King’s
College London; Nino Ku¨nzli, formerly University of Basel, now
University of Southern California Los Angeles; Be´ne´dicte Leynaert,
Institut National de la Sante´ et de la Recherche Me´dicale (INSERM);
Christina Luczynska, King’s College London; Franc¸oise Neukirch,
Institut National de la Sante´ et de la Recherche Me´dicale (INSERM); J
Schouten, University of Groningen; Jordi Sunyer, Institut Municipal
d’Investigacio´ Me`dica (IMIM-IMAS), Universitat Pompeu Fabra
(UPF); Cecilie Svanes, University of Bergen; Vermeire, University of
Antwerp; Matthias Wjst, GSF Institute of Epidemiology.
Principal Investigators and Senior Scientiﬁc Team
Australia: Melbourne (M Abramson, EH Walters, J Raven, S
Dharmage). Belgium: South Antwerp and Antwerp City (P Vermeire,
J Weyler, M Van Sprundel, V Nelen). Canada: Halifax (D Bowie),
Hamilton (MR Sears, HC Siersted); Montreal (MR Becklake, P Ernst);
Prince Edward Island (L Sweet, L Van Til); Vancouver (M Chan-
Yeung, H Dimich-Ward); Winnipeg (J Manfreda, NR Anthonisen).
Estonia: Tartu (R Jogi, A Soon). France: Paris (F Neukirch, B Leynaert,
R Liard, M Zureik); Grenoble (I Pin, J Ferran-Quentin). Germany:
Erfurt (J Heinrich, M Wjst, C Frye, I Meyer). Iceland: Reykjavik (T
Gislason, E Bjornsson, D Gislason, T Blondal, KB Jorundsdottir). Italy:
Turin (M Bugiani, P Piccioni, E Caria, A Carosso, E Migliore, G
Castiglioni); Verona (R de Marco, G Verlato, E Zanolin, S Accordini,
A Poli, V Lo Cascio, M Ferrari); Pavia (A Marinoni, S Villani, M
Ponzio, F Frigerio, M Comelli, M Grassi, I Cerveri, A Corsico).
Netherlands: Groningen and Geleen (J Schouten, M Kerkhof).
Norway: Bergen (A Gulsvik, E Omenaas, C Svanes, B Laerum). Spain:
Barcelona (JM Anto´, J Sunyer, M Kogevinas, JP Zock, X Basagana, A
Jaen, F Burgos); Huelva (J Maldonado, A Pereira, JL Sanchez);
Albacete (J Martinez-Moratalla Rovira, E Almar); Galdakao (N
Muniozguren, I Urritia), Oviedo (F Payo). Sweden: Uppsala (C Janson,
G Boman, D Norback, M Gunnbjornsdottir); Goteborg (K Toren, L
Lillienberg, AC Olin, B Balder, A Pfeifer-Nilsson, R Sundberg); Umea
(E Norrman, M Soderberg, K Franklin, B Lundback, B Forsberg, L
Nystrom). Switzerland: Basel (N Ku¨nzli, B Dibbert, M Hazenkamp, M
Brutsche, U Ackermann-Liebrich). United Kingdom: Norwich (D
Jarvis, B Harrison); Ipswich (D Jarvis, R Hall, D Seaton).
Funders
Financial support for ECRHS I centres: Allen and Hanbury,
Belgian Science Policy Ofﬁce, National Fund for Scientiﬁc Research;
Ministe`re de la Sante´, Glaxo France, Institut Pneumologique
d’Aquitaine, Contrat de Plan Etat-Re´gion Languedoc-Rousillon,
CNMATS, CNMRT (90MR/10, 91AF/6), Ministre delegue´ de la sante´,
RNSP, France; Health Canada, Province of Prince Edward Island,
Glaxo Canada; GSF, and the Bundesministerium fu¨r Forschung und
Technologie, Bonn, Germany; Ministero dell’Universita` e della
Ricerca Scientiﬁca e Tecnologica, CNR, Regione Veneto (RSF n.
381/05.93), Italy; Norwegian Research Council (101422/310); Dutch
Ministry of Wellbeing, Public Health and Culture, Netherlands;
Ministero Sanidad y Consumo FIS (91/0016060/00E-05E and 93/0393),
and grants from Hospital General de Albacete, Hospital General Juan
Ramo´n Jime´nenz, Consejeria de Sanidad Principado de Asturias,
Spain; The Swedish Medical Research Council, the Swedish Heart
Lung Foundation, and the Swedish Association against Asthma and
Allergy; Swiss National Science Foundation (4026–28099); National
Asthma Campaign, British Lung Foundation, Department of Health,
South Thames Regional Health Authority, UK; US Department of
Health, Education and Welfare Public Health Service (2 S07
RR05521–28) and Victorian Asthma Foundation.
The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
References
1. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, et al. (2004)
Rhinosinusitis: Establishing deﬁnitions for clinical research and patient
care. J Allergy Clin Immunol 114: 155–212.
2. Wjst M, Dold S, Reitmeir P, Stiepel E, von Mutius E (1992) Month of birth
and allergic disease at the age of 10. Clin Exp Allergy 22: 1026–1031.
3. Reed CE (1958) The failure of antepartum or neonatal exposure to grass
pollen to inﬂuence the later development of grass sensitivity. J Allergy 29:
300–301.
4. Kleiner H, Arkins JA, Lauwasser M (1975) Correlation between date of birth
and pollen sensitivity. Ann Allergy 34: 310–314.
5. Soothill JF, Stokes CR, Turner MW, Norman AP, Taylor B (1976)
Predisposing factors and the development of reaginic allergy in infancy.
Clin Allergy 6: 305–319.
6. Bjoerksten F, Suoniemi I (1976) Dependence of immediate hypersensitivity
on the month of birth. Clin Allergy 6: 165–171.
7. Pearson DJ, Freed DL, Taylor G (1977) Respiratory allergy and month of
birth. Clin Allergy 7: 29–33.
8. Smith JM, Springett VH (1979) Atopic disease and month of birth. Clin
Allergy 9: 153–157.
9. Kemp AS (1979) Relationship between the time of birth and the
development of immediate hypersensitivity to grass-pollen antigens. Med
J Aust 1: 263–264.
10. Bjorksten F, Suoniemi I, Koski V (1980) Neonatal birch-pollen contact and
subsequent allergy to birch pollen. Clin Allergy 10: 585–591.
11. Anderson HR, Bailey PA, Bland JM (1981) The effect of birth month on
asthma, eczema, hayfever, respiratory symptoms, lung function, and
hospital admissions for asthma. Int J Epidemiol 10: 45–51.
12. Pedersen PA, Weeke ER (1983) Month of birth in asthma and allergic
rhinitis. Scand J Prim Health Care 1: 97–101.
13. Korsgaard J, Dahl R (1983) Sensitivity to house dust mite and grass pollen in
adults. Inﬂuence of the month of birth. Clin Allergy 13: 529–535.
14. David TJ, Beards SC (1985) Asthma and the month of birth. Clin Allergy 15:
391–395.
15. Carosso A, Rufﬁno C, Bugiani M (1986) The effect of birth season on
pollenosis. Ann Allergy 56: 300–303.
16. Beck HI, Hagdrup HK (1987) Atopic dermatitis, house dust mite allergy and
month of birth. Acta Derm Venereol 67: 448–451.
17. Businco L, Cantani A, Farinella F, Businco E (1988) Month of birth and
grass pollen or mite sensitization in children with respiratory allergy: A
signiﬁcant relationship. Clin Allergy 18: 269–274.
18. Quoix E, Bessot JC, Kopferschmitt-Kubler MC, Fraisse P, Pauli G (1988)
Positive skin tests to aero-allergens and month of birth. Allergy 43: 127–
131.
19. Troise C, Voltolini S, Delbono G, Ebbli A, Negrini AC (1989) Allergy to
Parietaria pollen and month of birth. Allergol Immunopathol (Madr) 17:
201–204.
20. Tan KY, Voorhorst R (1978) Hay fever and month of birth. Allergol
Immunopathol (Madr) 6: 9–18.
21. Peinado Perez J, Fernandez Hidalgo D, Pantoja Bajo A, Perez Alvarez T,
Olmos Berrocoso A, et al. (1983) [Birth month as a predisposing factor in
allergic disease]. An Esp Pediatr 19: 29–32.
22. Tseng RY, Lam CW, Davies DP (1988) Cord blood IgE and month of birth.
Arch Dis Child 63: 573–574.
23. Strachan DP, Seagroatt V, Cook DG (1994) Chest illness in infancy and
chronic respiratory disease in later life: An analysis by month of birth. Int J
Epidemiol 23: 1060–1068.
24. Karachaliou FH, Panagiotopoulou K, Manousakis M, Sinaniotis K,
Papageorgiou F (1995) Month of birth, atopic disease, and sensitization
to common aeroallergens in Greece. Pediatr Allergy Immunol 6: 216–219.
25. Schaefer F, Wingen AM, Hennicke M, Rigden S, Mehls O (1996) Growth
charts for prepubertal children with chronic renal failure due to congenital
renal disorders. European Study Group for Nutritional Treatment of
Chronic Renal Failure in Childhood. Pediatr Nephrol 10: 288–293.
26. Eriksson NE, Holmen A (1996) Skin prick tests with standardized extracts of
inhalant allergens in 7099 adult patients with asthma or rhinitis: Cross-
sensitizations and relationships to age, sex, month of birth and year of
testing. J Investig Allergol Clin Immunol 6: 36–46.
27. Saryan JA, Bouras A (1996) Month of birth and sensitization to dust mites
in New England. Allergy Asthma Proc 17: 65–69.
28. Singh BP, Malhotra M, Sridhara S, Gaur SN (1997) Relevance of birth
month in respiratory allergy. Allergy 52: 232–233.
PLoS Medicine | www.plosmedicine.org October 2005 | Volume 2 | Issue 10 | e2940984
Latitude, Birth Date, and Allergy
29. Erel F, Karaayvaz M, Caliskaner Z, Ozanguc N (1998) The allergen spectrum
in Turkey and the relationships between allergens and age, sex, birth
month, birthplace, blood groups and family history of atopy. J Investig
Allergol Clin Immunol 8: 226–233.
30. Chew FT, Goh DY, Teo J, Quak SH, Lee BW (1998) Month of birth and
childhood atopic diseases in the tropics. Allergy 53: 962–968.
31. de Montis G (1999) [Reagin sensitizations and date of birth. Differences in
function according to family history]. Arch Pediatr 6: 259–262.
32. Kusunoki T, Asai K, Harazaki M, Korematsu S, Hosoi S (1999) Month of
birth and prevalence of atopic dermatitis in schoolchildren: Dry skin in
early infancy as a possible etiologic factor. J Allergy Clin Immunol 103:
1148–1152.
33. Vovolis V, Grigoreas C, Galatas I, Vourdas D (1999) Is month of birth a risk
factor for subsequent development of pollen allergy in adults? Allergy
Asthma Proc 20: 15–22.
34. Saitoh Y, Dake Y, Shimazu S, Sakoda T, Sogo H, et al. (2001) Month of birth,
atopic disease, and atopic sensitization. J Investig Allergol Clin Immunol
11: 183–187.
35. Guerra S, Sherrill DL, Cottini M, Michetti G, Allegra L (2002) On the
association between date of birth and pollen sensitization: Is age an effect
modiﬁer? Allergy Asthma Proc 23: 303–310.
36. Dik N, Tate RB, Manfreda J, Anthonisen NR (2004) Risk of physician-
diagnosed asthma in the ﬁrst 6 years of life. Chest 126: 1147–1153.
37. Strachan DP (1997) Allergy and family size: A riddle worth solving. Clin Exp
Allergy 27: 235–236.
38. Armitage EL, Aldhous MC, Anderson N, Drummond HE, Riemersma RA, et
al. (2004) Incidence of juvenile-onset Crohn’s disease in Scotland:
Association with northern latitude and afﬂuence. Gastroenterology 127:
1051–1057.
39. Staples JA, Ponsonby AL, Lim LL, McMichael AJ (2003) Ecologic analysis of
some immune-related disorders, including type 1 diabetes, in Australia:
Latitude, regional ultraviolet radiation, and disease prevalence. Environ
Health Perspect 111: 518–523.
40. Weiland SK, Husing A, Strachan DP, Rzehak P, Pearce N (2004) Climate and
the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema
in children. Occup Environ Med 61: 609–615.
41. Burney PG, Luczynska C, Chinn S, Jarvis D (1994) The European
Community Respiratory Health Survey. Eur Respir J 7: 954–960.
42. Sunyer J, Basagana X, Burney P, Anto JM (2000) International assessment of
the internal consistency of respiratory symptoms. European Community
Respiratory Health Study (ECRHS). Am J Respir Crit Care Med 162: 930–
935.
43. Cleveland WS (1993) Visualizing data. Summit (New Jersey): Hobart Press.
360 p.
44. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin
Trials 7: 177–188.
45. Reid AH, Taubenberger JK (2003) The origin of the 1918 pandemic
inﬂuenza virus: A continuing enigma. J Gen Virol 84: 2285–2292.
46. European Community Respiratory Health Survey (1996) Variations in the
prevalence of respiratory symptoms, self-reported asthma attacks, and use
of asthma medication in the European Community Respiratory Health
Survey (ECRHS). Eur Respir J 9: 687–695.
47. Schafer T, Przybilla B, Ring J, Kunz B, Greif A, et al. (1993) Manifestation of
atopy is not related to patient’s month of birth. Allergy 48: 291–294.
48. Tobias A, Soriano JB, Chinn S, Anto JM, Sunyer J, et al. (2001) Symptoms of
asthma, bronchial responsiveness and atopy in immigrants and emigrants
in Europe. European Community Respiratory Health Survey. Eur Respir J
18: 459–465.
49. Williams R (2005) Climate change blamed for rise in hay fever. Nature 434:
1059.
50. Kihlstrom A, Lilja G, Pershagen G, Hedlin G (2004) Maternal pollen allergy
may be more important than birch pollen exposure during pregnancy for
atopic airway disease in the child. Pediatr Allergy Immunol 15: 497–505.
51. Simpson A, Simpson B, Custovic A, Craven M, Woodcock A (2003)
Stringent environmental control in pregnancy and early life: The long-
term effects on mite, cat and dog allergen. Clin Exp Allergy 33: 1183–1189.
52. Sunyer J, Anto JM, Tobias A, Burney P (1999) Generational increase of self-
reported ﬁrst attack of asthma in ﬁfteen industrialized countries. European
Community Respiratory Health Study (ECRHS). Eur Respir J 14: 885–891.
53. Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, et al. (1997)
Worldwide variations in prevalence of symptoms of allergic rhinoconjunc-
tivitis in children: The International Study of Asthma and Allergies in
Childhood (ISAAC). Pediatr Allergy Immunol 8: 161–176.
54. Hyppoenen E, Sovio U, Wjst M, Patel S, Pekkanen J, et al. (2004) Infant
vitamin d supplementation and allergic conditions in adulthood: Northern
Finland birth cohort 1966. Ann N Y Acad Sci 1037: 84–95.
55. van der Wielen RP, Lowik MR, van den Berg H, de Groot LC, Haller J, et al.
(1995) Serum vitamin D concentrations among elderly people in Europe.
Lancet 346: 207–210.
56. Cavalli-Sforza LL (1991) Genes, peoples and languages. Sci Am 265: 104–
110.
Patient Summary
Background Allergy is becoming more common in many parts of the
world, but there is no satisfactory explanation for this, or for why the
number of people with allergies varies so much between countries. If
scientists knew more about where and when the risks of allergy are
highest, it might help them understand more about the condition and its
causes. Some research has suggested that the month in which one is
born can affect one’s risk of getting an allergy, although other studies
have not found this. The month of birth would determine how old a
baby was when it first encountered an allergy-causing substance (like
pollen) or an infection (like a cold), and this might turn out to be
important.
What Did The Researchers Do? They looked at one type of allergy:
allergic rhinitis, the inflammation of the membranes inside the nose that
is usually called hayfever. They gave a questionnaire to patients in 54
regions, mainly in Europe. More than 200,000 people responded, and
nearly a quarter of them had allergic rhinitis. Overall, the condition was
found to be more common further away from the Equator, although
there were some exceptions. However, the month of birth did not seem
to make a difference in the likelihood of getting allergy. The researchers
did find a variation in allergy rates according to which languages people
spoke. They suggest that this means there are genetic and cultural
factors involved in allergy risk.
What Does This Mean? This study was larger and used more reliable
methods than some earlier research, so we can be more confident of the
conclusions. The mystery of why allergy is becoming more common has
not been solved, but the researchers’ conclusion that genetic and
cultural factors are more important than geographical factors is an
advance in our knowledge.
More Information Online General information for suffers of allergy,
including hayfever, may be found on these Web sites.
The American Academy of Family Physicians:
http://familydoctor.org/083.xml
The American Academy for Asthma, Allergy and Immunology:
http://www.aaaai.org
Allergy UK, formerly the British Allergy Foundation:
http://www.allergyuk.org/allergy_whatis.html
For the big picture on asthma worldwide, try the World Allergy
Organization:
http://www.worldallergy.org
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